Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emmanuel Walter
Immunogenicity, Safety and Consistency of New Trivalent Inactivated Influenza Vaccine
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Related publications
Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children With Recurrent Wheezing
Clinical and Vaccine Immunology
Medicine
Immunology
Allergy
Clinical Biochemistry
Microbiology
Safety of Trivalent Inactivated Influenza Vaccine in Children Aged 24 to 59 Months in the Vaccine Safety Datalink
Archives of Pediatrics & Adolescent Medicine
Immunogenicity and Safety of an Egg-Based Inactivated Quadrivalent Influenza Vaccine (GC3110A) Versus Two Inactivated Trivalent Influenza Vaccines With Alternate B Strains: A Phase Ⅲ Randomized Clinical Trial in Adults
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Immunogenicity and Reactogenicity of High- Versus Standard-Dose Trivalent Inactivated Influenza Vaccine in Healthcare Workers: A Pilot Randomized Controlled Trial
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
538 Severity of Breakthrough Influenza Illness Among Children and Adults Receiving Live Attenuated Influenza Vaccine and Trivalent Inactivated Influenza Vaccine
Pediatric Research
Child Health
Pediatrics
Perinatology
Immunogenicity Studies in Human Subjects of Trivalent Tissue Culture Poliomyelitis Vaccine Inactivated by Ultraviolet Irradiation
American Journal of Public Health and the Nations Health
Discordance Between Antibody and T Cell Responses in Recipients of Trivalent Inactivated Influenza Vaccine
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health
Phase I Clinical Evaluation of Seasonal Influenza Hemagglutinin (HA) DNA Vaccine Prime Followed by Trivalent Influenza Inactivated Vaccine (IIV3) Boost
Contemporary Clinical Trials
Medicine
Pharmacology
Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza Vaccine
JAMA - Journal of the American Medical Association
Medicine
